B. Riley Has Strong Forecast for TG Therapeutics Q3 Earnings
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Analysts at B. Riley raised their Q3 2025 EPS estimates for shares of TG Therapeutics in a research note issued to investors on Monday, May 5th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will earn $0.40 per share for the quarter, up from […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – Analysts at B. Riley raised their Q3 2025 EPS estimates for shares of TG Therapeutics in a research note issued to investors on Monday, May 5th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will earn $0.40 per share for the quarter, up from […]
